Global Drug Discovery Informatics Market Worth USD 6,548.1 Million by 2022 - Analysis, Technologies & Forecasts Report 2012-2022 - Key Vendors: ChemAxon, Selvita, Infosys - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Drug Discovery Informatics Market Size & ForecastByWorkflow, By Mode, By Services And Trend Analysis From 2012 To 2022" report to their offering.

Global drug discovery informatics market is anticipated to reach USD 6,548.1 million by 2022. Ongoing improvement incomputational technology is anticipated to drive the adoption of in-silicotherapeutic product discovery models thus, influencing sector progress over the forecast period.

Drug discovery informatics industry is estimated to witness lucrative growth over the forecast period majorly due to, the rising number of technologically advanced products in the field of drug development. Significant shift observed from traditional in-vitro drug development to computer aided drug designing, as costly failures of late drug development increases the use of in-silico models for early ADME/Toxicity screening is anticipated to propel progress in this sector.

Furthermore, R&D carried out in the field of information technology for the facilitation of analytics and visualization applications that enable data aggregation and processing is attributive for driving growth in this market through to 2022.

Discovery informatics dominated accounting for the largest share of the market in 2014 owing to presence of substantial number of in-silico tools and databases in this segment, which aid the process of lead identification and validation.

Development informatics is anticipated to witness substantial progress in the coming years because of upcoming development in the sub segments that involve clinical trial data management services and softwares.

Companies Mentioned:

  • ChemAxon
  • GVK Biosciences
  • Jubilant Biosys
  • Selvita
  • Certara
  • Infosys
  • Albany Molecular Research Inc.
  • BoehringerIngelheimGmBh
  • DiscoverX
  • Charles River Laboratories
  • Covance

Report Structure:

1. Methodology and Scope

2. Executive Summary

3. Drug Discovery InformaticsIndustry Outlook

4. Drug Discovery InformaticsOutlook, by Workflow

5. Drug Discovery InformaticsOutlook, By Mode

6. Drug Discovery InformaticsOutlook, By Services

7. Drug discovery informaticsRegional Outlook (Revenue, USD Million, 2012 - 2022)

8. Competitive Landscape

For more information visit http://www.researchandmarkets.com/research/hlhwv8/drug_discovery

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716